XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > oh..whats this.....20% up?

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Oct 21, 2021 3:16pm

269 Views

Post# 34034142

RE:oh..whats this.....20% up?

This is BULLCRAP by a REDNECK from Calgary, our Honorable CEO Allen 'Doff.

CEO has HIRED an Investor Relations who is wanted in NY?. He engaged with CEO and his chronicle BOARD of DIRECTORS to FLUSH out the GRASSROOTS who have been kept in the DARK !!.
NY Paddlers to HATCH a VERY LOW IPO? We got ROLLED BACK from $9 /shr.

CEO, Allen and your BOD has to calculate WHO are you ENTERTAINING here???

REPORT XRX CEO to SEC in USA before it is TOO LATE folks !